Article

barrons.com on 2021-09-02 14:57

AbbVie Stock Dropped After FDA Warning. Analysts Say Selloff Is Overblown.3 min read

The regulator said a class of drug known as JAK inhibitors increased the risk of cancer, serious heart-related events, and death.

Related news